
Twelve researchers who conduct research at the DKFZ or lead joint bridge departments with the DKFZ have reached the very top in 2026: They rank among the top 1 percent of the world’s most-cited researchers in their respective fields. 👏 t1p.de/symxo

Univ. Prof. Director The M3 Research Center UKT Division Head German Cancer Research Center Chronic Inflammation and Cancer Views are my own

Twelve researchers who conduct research at the DKFZ or lead joint bridge departments with the DKFZ have reached the very top in 2026: They rank among the top 1 percent of the world’s most-cited researchers in their respective fields. 👏 t1p.de/symxo

Jessica Zucman-Rossi, Alice Kamphorst, Matthias Heikenwälder, and Fasiha Kanwal will discuss "Molecular Pathogenesis and Risk Factors For HCC" in a plenary at #AACRliver26 (December 6-8; Austin). brnw.ch/21x6wmZ @Zucmanrossi @KamphorstAlice @CancerInflam @KanwalFasiha

Nature review: Molecular mechanisms and pathogenesis of MASH go.nature.com/4i5T1V3

It was a plasure and honor to write this review with Suchira Gallage, Olivier Govaere, Quentin Anstee, Gerald Shulman and Frank Tacke. We start to understand more and more about the most prevalent liver disease - still much to be learned-on pathogenesis, prevention and therapy.
A state-of-the science 5 ★ review of MASH (fatty liver with inflammation, nonalcoholic). Awareness of this important, highly prevalent, often undiagnosed condition has increased in recent years, and now the interventions to go after it have blossomed (Figure) @Nature @CancerInflam @GallageSuchira nature.com/articles/s41586-0…

A state-of-the science 5 ★ review of MASH (fatty liver with inflammation, nonalcoholic). Awareness of this important, highly prevalent, often undiagnosed condition has increased in recent years, and now the interventions to go after it have blossomed (Figure) @Nature @CancerInflam @GallageSuchira nature.com/articles/s41586-0…

Congratulations to Ki Hong Lee & Moritz Jakab for their landmark paper in @NatureComms showing that endothelial cell Wnt-mediated angiocrine signaling in the liver is controlled by hemodynamic forces and not by oxygen gradients. Stunningly beautiful work! nature.com/articles/s41467-0…

Ready to lead your own research group? 🔬 The science may be familiar but what about managing a team, securing funding, building a research programme and planning a sustainable career?🫣 The next episode of #TalkLiverToMe explores what research independence really looks like. ℹ️easl.eu/event/what-nobody-te… @C_V_Schneider @CancerInflam @RautouE @Mandorf1 @IsraelsenMads @ZanettoAlberto #LiverX

Very proud to have written this EASL postion paper togehter with so many fantastic people - as well as to have done this #talklivertoME episode with Rui and Suchira - always a pleasure.
New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/art… 📺easlcampus.eu/tltm/episode-1… 🎙️open.spotify.com/episode/524… 🎙️podcasts.apple.com/us/podcas… @JHepatology #LiverX

New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/art… 📺easlcampus.eu/tltm/episode-1… 🎙️open.spotify.com/episode/524… 🎙️podcasts.apple.com/us/podcas… @JHepatology #LiverX
New Talk Liver to Me podcast coming up this Wednesday! 🐭 Can a mouse truly model human steatotic liver disease? And does the perfect preclinical model even exist? In the upcoming episode, we will explore the new EASL position paper on preclinical SLD models with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they will discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data. 👉 Read more easl.eu/event/chasing-the-pe… 📰 Access the position paper that will be discussed! pubmed.ncbi.nlm.nih.gov/4219… @GallageSuchira @CancerInflam @RuiCastroHD

Proud of the new work by my colleagues @GallageSuchira and @CancerInflam: journal-of-hepatology.eu/art… An important guideline on how to use preclinical models to study the pathobiogy of fatty liver disease. @EASLnews @DKFZ @EASLedu @JHepatology

🧫 New multisociety consensus on PSVD 🗣️ L. Elkrief | #EASLCongress 🔬 PSVD & NCPF now interchangeable ⚠️ Biopsy mandatory | can be diagnosed WITHOUT portal hypertension 💡 First globally endorsed framework (EASL/AASLD/APASL/ALEH) 🔗 journal-of-hepatology.eu/art…

This will become extremely useful to the scientific community. What mouse model to use in order to mimic steatotic liver disease (SLD), which in vitro models, what to take care of, what to analyse - we have integrated recommendations and introduced the state of the art models.

Thank you to Suchira Gallage, Rui Castro, Jennifer Estall, Ira Tabas, Quentin Anstee, Dina Tiniakos Gyongyi Szabo, Jun Yu, Chantal Desdouets, Frank Tacke and, Fiona Oakley - it was more than a pleasure to work on this with you - @EASLnews @EASLedu @JHepatology

The "EASL position paper on preclinical models of steatotic liver disease" is out - a great team effort. sciencedirect.com/science/ar…

Early Sat am ☕️ at #EASL2026, but definitely worth waking up for exciting new data and discussions 💡 on “#MASLD-related #HCC: Pathogenesis, Immunology and Treatment” chaired by @CancerInflam and @MarcoSanduzzi See you there! @derekamann1 @EASLnews pag.virtual-meeting.org/easl…

This will be an excellent scientific session at EASL 2026 congress on HCC in the background of metabolic liver disease. It’s an early morning session on 30th May but is going to be well worth the early morning wake up! @EASLnews @CancerInflam @Valeriechew29